Poor performance on quality metrics carried greater risk of in-hospital mortality no matter where patients initially ...

Do the survival and MI-prevention benefits extend to stable CAD patients? In the COURAGE trial, 2287 patients (mean age, 62; 85% men; 33.5% with diabetes) were randomized to PCI plus optimal ...

The global coronary artery bypass graft market is projected to reach USD 18,700.6 million by 2025 and continue its upward trajectory with a CAGR of 2.9%, reaching approximately USD 24,887.3 million by ...

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) with stable coronary ...

CAD is the most common type of heart disease ... Percutaneous coronary intervention (PCI) is a minimally invasive procedure to open blocked arteries using a stent. In this procedure, a ...

CAD remains one of the leading causes of death worldwide. In addition to traditional treatments like coronary artery bypass grafting (CABG) and percutaneous coronary interventions (PCI), several ...

Completed first quarter as a public company and raised $10.6 mil CAD concurrent with listing – Next-generation Novasight design freeze completed on schedule, usability testing and system validation ...

Johnson & Johnson has rewarded shareholders with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

Treatment effects on inflammation – Patients received antithrombotic and statin therapy post-PCI, which may have ... prevalence of pre-existing coronary artery disease (83% vs.

the majority of whom had surgery >6 months after PCI. Among patients with coronary artery disease who underwent any noncardiac surgery in the contemporary era, there was no observed increase in major ...